SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001718108-22-000019
Filing Date
2022-08-03
Accepted
2022-08-03 06:56:11
Documents
66
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q surf-20220630.htm   iXBRL 10-Q 1295217
2 EX-31.1 surf-06302022xexx311.htm EX-31.1 10214
3 EX-31.2 surf-06302022xexx312.htm EX-31.2 10014
4 EX-32.1 surf-06302022xexx321.htm EX-32.1 5148
5 EX-32.2 surf-06302022xexx322.htm EX-32.2 4856
  Complete submission text file 0001718108-22-000019.txt   6364198

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT surf-20220630.xsd EX-101.SCH 43527
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT surf-20220630_cal.xml EX-101.CAL 52005
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT surf-20220630_def.xml EX-101.DEF 253279
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT surf-20220630_lab.xml EX-101.LAB 568446
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT surf-20220630_pre.xml EX-101.PRE 387170
60 EXTRACTED XBRL INSTANCE DOCUMENT surf-20220630_htm.xml XML 995752
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38459 | Film No.: 221130851
SIC: 2836 Biological Products, (No Diagnostic Substances)